Related Experiment Video
Updated: Feb 13, 2026

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155/CDX1 axis
Ruinian Zheng1, Shunhuan Lin1, Ling Guan2
1Department of Oncology, Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Abstract:
Long non-coding RNA (lncRNA) is an important member of non-coding RNA family and emerging evidence has indicated that it plays a pivotal role in many physiological and pathological processes. The lncRNA X inactive specific transcript (XIST) is a potential tumour suppressor in some types of cancers. However, the expression and function of XIST in breast cancer remain largely unclear. The objective of this study was to evaluate the expression and biological role of XIST in breast cancer. The results showed that XIST was significantly down-regulated in breast cancer tissues and cell lines. Further functional analysis indicated that overexpression of XIST remarkably inhibited breast cancer cell growth, migration, and invasion. The results of luciferase reporter assays verified that miR-155 was a direct target of XIST in breast cancer. Moreover, caudal-type homeobox 1 (CDX1) was identified as a direct target of miR-155 and miR-155/CDX1 rescued the effects of XIST in breast cancer cells. Taken together, our results suggest that XIST is down-regulated in breast cancer and suppresses breast cancer cell growth, migration, and invasion via the miR-155/CDX1 axis.
Insights
Long non-coding RNA XIST (X inactive specific transcript) is downregulated in breast cancer, suppressing tumor growth and spread. It acts through the miR-155/CDX1 pathway, offering potential therapeutic targets for breast cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are key regulators in cellular processes.
- X inactive specific transcript (XIST) shows potential as a tumor suppressor, but its role in breast cancer is not well understood.
Purpose of the Study:
- To investigate the expression and function of XIST in breast cancer.
- To elucidate the molecular mechanism underlying XIST's role in breast cancer.
Main Methods:
- Quantitative real-time PCR to assess XIST expression.
- Cell proliferation, migration, and invasion assays to evaluate XIST function.
- Luciferase reporter assays to identify direct targets of XIST and miR-155.
Main Results:
- XIST expression was significantly decreased in breast cancer tissues and cell lines.
- Overexpression of XIST inhibited breast cancer cell proliferation, migration, and invasion.
- XIST directly targets miR-155, which in turn targets CDX1, forming the XIST/miR-155/CDX1 axis.
Conclusions:
- XIST is downregulated in breast cancer and acts as a tumor suppressor.
- The XIST/miR-155/CDX1 axis plays a critical role in regulating breast cancer progression.
- XIST represents a potential therapeutic target for breast cancer treatment.
More Related Videos
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
08:08Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Feedback Inhibition
Hypothalamic-Pituitary Axis